These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Biological activity of vitamin D3 derivatives in inducing differentiation of HL-60 human promyelocytic leukemia cells.
    Author: Yoshida M, Ishizuka S, Hoshi A.
    Journal: J Pharmacobiodyn; 1984 Dec; 7(12):962-8. PubMed ID: 6099852.
    Abstract:
    Induction of cell differentiation by twenty-one derivatives of vitamin D3 and their binding affinity for the receptor of 1 alpha,25-dihydroxyvitamin D3, an active vitamin D3 metabolite, were examined using HL-60 human promyelocytic leukemia cells and chick intestinal cytosol, respectively. 1 alpha,24(R)-dihydroxy-26-chlorovitamin D3 is found to be more active than 1 alpha,24(R)-dihydroxyvitamin D3 and 1 alpha,25-dihydroxyvitamin D3 in the two abilities to induce the differentiation and to bind to the receptor. The results suggest that a hydroxy group at C-1 position of vitamin D3 and a hydroxy or oxo group at C-25 or C-24 position are essential for both abilities. In diastereoisomers of 1 alpha,25-dihydroxyvitamin D3-26,23-lactone, synthesized (23 S,25 S) 1 alpha,25-dihydroxyvitamin D3-26,23-lactone was more active in both abilities than the natural metabolite, (23 S,25 R) 1 alpha,25-dihydroxyvitamin D3-26,23-lactone, which shows anti-vitamin D action.
    [Abstract] [Full Text] [Related] [New Search]